Update on Drug-Eluting Stents

被引：3
作者：
Sims, Jennifer M. [1 ]
机构：
[1] Cardiol Kentucky, 4003 Kresge Way, Louisville, KY 40207 USA
来源：
DIMENSIONS OF CRITICAL CARE NURSING | 2007年 / 26卷 / 06期
关键词：
Stents; Drug-eluting stent; Percutaneous transluminal Coronary angioplasty; Coronary artery disease;
D O I：
10.1097/01.DCC.0000297397.58445.ec
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
Coronary artery disease is the number 1 killer of Americans. There are many efforts underway to prevent and treat this life-threatening disease. One such treatment is the placement of drug-eluting stents. However, recent reports that show an increased risk of potentially life-threatening complications associated with drug-eluting stents have surfaced. This article provides a brief overview of research performed concerning the risks of drug-eluting stents.
引用
收藏
页码：237 / 240
页数：4
相关论文
共 50 条
  • [31] Current application and bioavailability of drug-eluting stents
    Escarcega, Ricardo O.
    Baker, Nevin C.
    Lipinski, Michael J.
    Magalhaes, Marco A.
    Minha, Sa'ar
    Omar, Al-Fazir
    Torguson, Rebecca
    Waksman, Ron
    EXPERT OPINION ON DRUG DELIVERY, 2014, 11 (05) : 689 - 709
  • [32] In Vitro Dissolution Testing of Drug-Eluting Stents
    Seidlitz, Anne
    Nagel, Stefan
    Semmling, Beatrice
    Sternberg, Katrin
    Kroemer, Heyo K.
    Weitschies, Werner
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2013, 14 (01) : 67 - 75
  • [33] Drug-eluting stents from cardiology to pneumonology
    Zarogoulidis, Paul
    Huang, Haidong
    Freitag, Lutz
    FUTURE CARDIOLOGY, 2024, 20 (7-8) : 335 - 337
  • [34] Impact of Drug-Eluting Stents on Distal Vessels
    Wakabayashi, Kohei
    Mintz, Gary S.
    Weissman, Neil J.
    Stone, Gregg W.
    Ellis, Stephen G.
    Grube, Eberhard
    Ormiston, John A.
    Turco, Mark A.
    Pakala, Rajbabu
    Xue, Zhenyi
    Desale, Sameer
    Laynez-Carnicero, Ana
    Romaguera, Rafael
    Sardi, Gabriel
    Pichard, Augusto D.
    Waksman, Ron
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2012, 5 (02) : 211 - 219
  • [35] New drug-eluting stents with biodegradable polymers
    Van Der Giessen, W. J.
    Van Beusekom, H. M. M.
    MINERVA CARDIOANGIOLOGICA, 2011, 59 (01): : 31 - 37
  • [36] Bioresorbable Drug-Eluting Stents No Pain, No Gain
    Harada, Yukinori
    Byrne, Robert A.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (12) : 1228 - 1230
  • [37] Outcome Differences With the Use of Drug-Eluting Stents for the Treatment of In-Stent Restenosis of Bare-Metal Stents Versus Drug-Eluting Stents
    Steinberg, Daniel H.
    Gaglia, Michael A., Jr.
    Slottow, Tina L. Pinto
    Roy, Probal
    Bonello, Laurent
    De Labriolle, Axel
    Lemesle, Gilles
    Torguson, Rebecca
    Kineshige, Kimberly
    Xue, Zhenyi
    Suddath, William O.
    Kent, Kenneth M.
    Satler, Lowell F.
    Pichard, Augusto D.
    Lindsay, Joseph
    Waksman, Ron
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (04) : 491 - 495
  • [38] Drug-eluting stents Implications for surgery patients
    Boeluekbas, S.
    Jaehne, J.
    Schirren, J.
    CHIRURG, 2009, 80 (06): : 502 - 507
  • [39] Molecular basis of restenosis and drug-eluting stents
    Costa, MA
    Simon, DI
    CIRCULATION, 2005, 111 (17) : 2257 - 2273
  • [40] Therapy Insight: diabetes and drug-eluting stents
    Legrand, Victor
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2007, 4 (03): : 143 - 150
12345